Evidence map›Paper›PMID 35125757›Full record

ArticleIndian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India

Evaluation of Plasma Amyloid Peptides Aβ

Hariom Soni, Manoj Kumar Goyal, Phulen Sarma, Harmandeep Singh, Manish Modi, Anchal Sharma, Manju Mohanty, Venugopalan Y Vishnu, Ashok Kumar, Bhagwant Rai Mittal and 1 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Alzheimer's disease plasma biomarkers in the Midwestern Amish.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  3. Prognostic value of plasma Aβ1-40 for Alzheimer's disease.American journal of translational research · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Hariom SoniDepartment of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Manoj Kumar GoyalDepartment of Neurology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Phulen SarmaDepartment of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Harmandeep SinghDepartment of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Manish ModiDepartment of Neurology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Anchal SharmaDepartment of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Manju MohantyDepartment of Neurosurgery, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Venugopalan Y VishnuDepartment of Neurology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Ashok KumarDepartment of Neurology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Bhagwant Rai MittalDepartment of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Bikash MedhiDepartment of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Post Graduate Institute of Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe estimated plasma amyloid-peptides levels (Aβ PATIENTS AND

methodsA case-control study was conducted. Diagnostic and statistical manual-IV, Dubois, and NIA-AA criteria were used for the diagnosis of AD. The plasma Aβ

resultsForty-seven cognitive impairment patients (AD = 29, mild cognitive impairment = 18) and 33 age-matched controls were enrolled. Plasma Aβ

conclusionAs a diagnostic biomarker of AD, plasma Aβ

Indexed as

18F-fluorodeoxyglucose positron emission tomographyAlzheimer's diseaseAβ1-40Aβ1-42diagnostic biomarkermild cognitive impairment

Identifiers

PMID35125757
PMCPMC8771055
OpenAlexW4206776556

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.